eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystoid macular dystrophy |
| Comorbidity | C0035309|retinopathy |
| Sentences | 30 |
| PubMedID- 22937513 | Aim: to determine the risk factors of clinically significant macular edema (csme) in patients with non-proliferative diabetic retinopathy (npdr) in a multi-ethnics malaysian population. |
| PubMedID- 22983424 | In addition, it induces vascular hyperpermeability leading, for example, to central macular edema in patients with diabetic retinopathy [33] or retinal vein occlusion [34]. |
| PubMedID- 24349522 | In this study, we introduce choroidal area (ca; µm2) as a new parameter for analyzing choroidal quantity by edi sd-oct. ca can be used to interpret the choroidal factors that contribute to smd in non-proliferative diabetic retinopathy (npdr) patients with diabetic macular edema (dme). |
| PubMedID- 25975823 | Severe retinopathy and presence of diabetic macular edema (dme) are associated with vision loss in patients with diabetes [1]. |
| PubMedID- 22224029 | The fundus exam showed severe bilateral nonproliferative diabetic retinopathy, with greater macular edema in the right eye compared to the left eye. |
| PubMedID- 25636266 | Triamcinolone acetonide (ta), as a long-term glucocorticoid, has been proved to be effective for treating macular edema associated with diabetic retinopathy (dr) and ischemic central retinal vein occlusion (crvo) [7, 8]. |
| PubMedID- 20627932 | Alterations in brb occur early in the progression of diabetic retinopathy and eventually lead to macular edema, which is responsible for vision loss (2). |
| PubMedID- 24348012 | Fundus examination of the right eye showed nonproliferative diabetic retinopathy with macular edema and a swollen optic disk. |
| PubMedID- 21348230 | We report a case of sle retinopathy concurrent with macular edema and ischemic optic neuropathy. |
| PubMedID- 20642348 | Results: in type 1 diabetes patients we observed a prevalence of 36.47% of diabetic retinopathy and 5.73% with macular edema; in type 2 diabetes patients the prevalence of diabetic retinopathy was 26.11% and 6.44% with macular edema. |
| PubMedID- 24707120 | Diabetic eye disease with its complications, especially diabetic retinopathy that leads to macular edema and retinal neovascularization, is the leading cause of visual dysfunction and blindness among adult working-age population in economically developed societies worldwide. |
| PubMedID- 26106919 | We review developments in regenerative medicine (e.g., retinal prosthesis, optogenetics, cell-based therapy), diagnostics (e.g., swept source optical coherence tomography [oct], intraoperative oct, multimodal imaging), surgical innovations (e.g., chemical vitreolysis with ocriplasmin, 27-gauge vitrectomy), and pharmacological therapy of retinal vascular disease (e.g., use of ranibizumab and aflibercept in the treatment of macular edema associated with diabetic retinopathy and retinal vein occlusion). |
| PubMedID- 22548042 | cystoid macular edema developed in a patient with diabetic retinopathy and neovascular glaucoma. |
| PubMedID- 24959068 | Background: this study evaluated the effect of intravitreal injection of bevacizumab (ivb) on macular edema associated with diabetic retinopathy (dme) or branch retinal vein occlusion (brvome) using laser speckle flowgraphy. |
| PubMedID- 24978668 | Conclusion: we demonstrated a significantly reduced sensitivity in both nonproliferative diabetic retinopathy groups without diabetic macular edema compared with healthy controls; this reduction was greater in type 2 diabetic patients. |
| PubMedID- 20110406 | Vision loss in diabetic retinopathy is due to macular edema characterized by increased vascular permeability, which involves phosphorylation associated with activation of protein kinase c (pkc) isoforms. |
| PubMedID- 22509700 | Proliferative retinopathy, with cataract and macular edema, was identified in both eyes. |
| PubMedID- 25613583 | Twenty (40 %) patients had severe non-proliferative diabetic retinopathy with mild macular edema, which is the most prevalent type among the cases group. |
| PubMedID- 23807186 | Purpose: to evaluate whether intravitreal ranibizumab injection at cataract surgery prevents postoperative diabetic macular edema (pme) in patients with stable diabetic retinopathy without significant macular edema. |
| PubMedID- 25389894 | Bilateral radiation retinopathy with macular edema was diagnosed after the possibility of relapse was ruled out. |
| PubMedID- 20393241 | Materials and methods: an observational case-study which included 180 type 2 diabetic patients (180 eyes) of nonproliferative diabetic retinopathy (npdr) with clinically significant macular edema (csme). |
| PubMedID- 23961505 | Fundus examination revealed bilateral severe proliferative diabetic retinopathy with macular edema and grade 2 hypertensive retinopathy. |
| PubMedID- 24363502 | Diabetic eye disease with its complications, especially diabetic retinopathy which leads to macular edema and retinal neovascularization, is the leading cause of visual dysfunction and blindness among working-aged adults in economically developed societies worldwide. |
| PubMedID- 24707168 | Patients were divided into three groups: mild–moderate nonproliferative diabetic retinopathy without macular edema (npdr), mild–moderate nonproliferative diabetic retinopathy with macular edema (dme), and proliferative diabetic retinopathy (pdr). |
| PubMedID- 22279402 | Posterior segment examination [figures 1 and 2] showed mild nonproliferative diabetic retinopathy without diabetic macular edema and a normal looking optic disc od with a small cup-to-disc (cd) ratio (0.1). |
| PubMedID- 23959793 | Diabetic macular edema results from progressive retinopathy related to chronic hyperglycemic and inflammatory vascular damage. |
| PubMedID- 24843311 | All the patients had proliferative diabetic retinopathy with chronic macular edema. |
| PubMedID- 25389718 | Difluprednate ophthalmic emulsion 0.05% as adjunctive treatment to panretinal photocoagulation for proliferative diabetic retinopathy with clinically significant macular edema. |
| PubMedID- 21772983 | The purpose of this study was to evaluate the effectiveness of intravitreal ranibizumab (lucentis, genentech, south san francisco, calif, usa) combined with cataract surgery for the prevention of clinically significant macular edema (csme) in patients with diabetic retinopathy (dr). |
| PubMedID- 20534920 | Two patients who had bcva < 20/200 had preexisting diabetic retinopathy with macular edema. |
Page: 1